FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is application of arbidol (1-methyl-2-phenylthiomethyl-3-carb-ethoxy-4-dimethilamino-methyl-5-oxy-6-bromidole of monohydrate hydrochloride) or its pharmaceutically acceptable salts and/or hydrates for manufacturing topic medications, intended for treatment of inflammatory and allergic skin diseases and topic pharmaceutical composition on its basis.
EFFECT: demonstrated is therapeutic action - reduction of skin affection on standard models of allergic and contact dermatitis with minimal number of side effects.
5 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION EXHIBITING ANTI-INFLAMMATORY, PARTICULARLY ANTIASTHMATIC ACTION, APPLICATIONS OF PHARMACEUTICAL COMPOSITION (VERSIONS) AND DRUG (VERSIONS) | 2008 |
|
RU2406498C2 |
MEDICINAL AGENT FOR TREATMENT OF ATYPICAL PNEUMONIA | 2004 |
|
RU2256451C1 |
1-METHYL-2-PHENYLTHIOMETHYL-3-CARBETHOXY-4-DIMETHYLAMINOMETHYL-5- HYDROXY-6 -BROMOINDOLE MESYLATE ELICITING ANTIVIRAL ACTIVITY AND PHARMACEUTICAL COMPOSITION WITH ITS USAGE | 2004 |
|
RU2255086C1 |
PHARMACEUTICAL DRUG FOR TREATING ROTAVIRUS INFECTION CASES | 2004 |
|
RU2266742C1 |
PROTEIN KINASE C INHIBITORS | 2009 |
|
RU2421219C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIDIABETIC, HYPOLIPIDEMIC, HYPOGLYCEMIC AND CHOLESTEROL LOWERING ACTION, WAY OF ITS RECEPTION AND WAYS OF TREATMENT OF SPECIFIED DISEASES | 2007 |
|
RU2361581C2 |
PROPHYLACTIC AND CURATIVE AGENT FOR TREATING FLU VIRUS B | 1986 |
|
RU2008004C1 |
GEL POSSESSING ANTI-INFLAMMATORY, IMMUNOTROPIC, ANTIALLERGIC AND WOUND HEALING ACTION | 2011 |
|
RU2457864C1 |
GEL, POSSESSING ANTI- INFLAMMATORY AND ANTIALLERGIC EFFECT | 2008 |
|
RU2370265C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES | 2013 |
|
RU2553600C2 |
Authors
Dates
2011-08-20—Published
2009-11-19—Filed